网站主页 > 化工产品目录 > 生物化工 > 抑制剂 > 丝裂原活化蛋白激酶(MAPK) > Raf 抑制剂 > ZM 336372

ZM 336372

ZM 336372 更多供应商
公司名称: 上海波以尔化工有限公司  
联系电话:
产品介绍: 英文名称:ZM 336372
CAS:208260-29-1
公司名称: 百灵威科技有限公司  
联系电话: 400-666-7788 +86-10-82848833
产品介绍: 英文名称:ZM 336372
CAS:208260-29-1
包装信息:2.5g,250Mg 备注:化学试剂、精细化学品、医药中间体、材料中间体
公司名称: 武汉易泰科技有限公司上海分公司  
联系电话: 86-21-50328103 * 801、802、803、804 Mobile:18930552037
产品介绍: 英文名称:ZM 336372;3-(DiMethylaMino)-N-[3-[(4-hydroxybenzoyl)-aMino]-4-Methylphenyl]benzaMide
CAS:208260-29-1
纯度:99% HPLC 包装信息:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
公司名称: 上海佰世凯化学科技有限公司  
联系电话: +86(0)21-20908456
产品介绍: 英文名称:ZM 336372
CAS:208260-29-1
备注:C14484
公司名称: 上海源鼎化学科技有限公司  
联系电话: +86 (21) 5772-1279,+86 (21) 6775-2378
产品介绍: 英文名称:3-(diMethylaMino)-N-(3-(4-hydroxybenzaMido)-4-Methylphenyl)benzaMide
CAS:208260-29-1
纯度:98% 包装信息:10g, 1kg, on request
最新发布供应信息
ZM 336372_Wuhan Sensedawn Science & Technology Co.,Ltd
2016/4/8 14:05:32
ZM 336372
生物活性 体外研究
中文名称:ZM 336372
中文同义词:CS-44;3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺;ZM 336372;ZM-336372
英文名称:ZM 336372
英文同义词:ZM 336372 - CAS 208260-29-1 - Calbiochem;N-[5-(3-DIMETHYLAMINOBENZAMIDO)-2-METHYLPHENYL]-4-HYDROXYBENZAMIDE;ZM 336372;3-(DIMETHYLAMINO)-N-[3-[(4-HYDROXYBENZOYL)-AMINO]-4-METHYLPHENYL]BENZAMIDE;Zinc00581684;3-(diMethylaMino)-N-(3-(4-hydroxybenzaMido)-4-Methylphenyl)benzaMide;Benzamide, 3-(dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]-;ZM 336372 3-(Dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]benzamide
CAS号:208260-29-1
分子式:C23H23N3O3
分子量:389.45
EINECS号:
相关类别:小分子抑制剂;小分子抑制剂,天然产物;Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;A potent and specific inhibitor of the protein kinase c-Raf.;MAPK;Inhibitors
Mol文件:208260-29-1.mol
ZM 336372
ZM 336372 性质
密度 1.298
储存条件 -20°C
溶解度 DMSO: >5mg/mL (warmed)
形态powder
颜色white to beige
敏感性 Light Sensitive
ZM 336372 用途与合成方法
生物活性ZM 336372是一种有效的,选择性的c-Raf抑制剂,IC50为70 nM,比作用于B-RAF选择性高10倍,对PKA/B/C, AMPK, p70S6等没有抑制作用。
体外研究ZM 336372 shows 10-fold selectivity over B-Raf. ZM 336372 weakly inhibits SAPK2a/p38α and SAPK2b/p38β with IC50 of 2 μM, and is selective over 17 other protein kinases including PKA, PKC, AMPK, p42 MAPK, MKK1, SAPK1/JNK, and CDK1 even at the concentration of up to 50 μM. ZM 336372 does not prevent constitutive as well as growth factor or phorbol ester induced activation of MKKl or p42 MAPK/ERK2. Moreover, ZM 336372 dose not reverse the phenotype of Ras- or Raf-transformed cell lines. ZM 336372 treatment induces >100 activation of c-Raf and the B-Raf isoform, but it does not trigger any activation of MKKI or p42 MAPK/ERKP or induce any increase in the GTP-loading of Ras, suggesting that a feedback control loop exists by which Raf isoforms suppress their own activation, such that inhibition is always counterbalanced by reactivation. ZM 336372-induced activation of c-Raf is not prevented by inhibition of the MAPK cascade, protein kinase C or phosphatidylinositide 3-kinase. ZM 336372 (1 μM) abolishes the upregulation of eNOS after treatment with hydrogen peroxide. ZM 336372 treatment in carcinoid tumor cells results in progressive phosphorylation of Raf-1, mitogen-activated protein kinase 1/2, and extracellular signal-regulated kinase 1/2, and causes a significant reduction of bioactive hormone levels as well as the transcription factor, human achaete-scute homologue-1. Furthermore, ZM 336372 treatment leads to a marked suppression of cellular proliferation and induction of the cell cycle inhibitors p21 and p18. ZM 336372 inhibits the proliferation of pheochromocytoma cells, and suppresses NE vasoactive peptide production. ZM 336372 treatment in HepG2 induces the suppression of proliferation in a dose-dependent manner, suppression of hormone secretion, and up-regulation of cell cycle inhibitors. ZM 336372 also induces apoptosis in pancreatic adenocarcinoma cell lines by inhibiting glycogen synthase kinase-3β through phosphorylation of GSK-3β at Ser 9.
安全信息
WGK Germany 3
"ZM 336372" 相关产品信息()
SB216763 ZM 447439 Quizartinib (AC220) Linifanib (ABT-869) 2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 Barasertib (AZD1152-HQPA)